 |
 |
In reply to the question from Gerry Haines, "if it is not approved in the US, how you have been taking for years?" I was a test subject in the initial entacapone safety test in the US (the SEESAW program) and have continued as a participant in the ongoing study. The testing is under the aegis of the PSG [Parkinson's Study Group]. I am evaluated periodically and intensively at the Robert Wood Johnson Medical School in New Brunswick, New Jersey. Will Johnston ---------- From: Gerry & Brig Haines <[log in to unmask]> To: Multiple recipients of list PARKINSN <[log in to unmask]> Subject: Re: Tasmar replacement? Date: Wednesday, December 02, 1998 6:05 AM In a message dated 12/2/98 12:14:06 AM Eastern Standard Time, [log in to unmask] writes: << According to fairly reliable sources, entacapone will be marketed in Europe as COMTESS and in the US as COMTAN. There is only slight chance that FDA approval could come before the middle of next summer. There are no reports of liver damage from entacapone. I have been taking entacapone for several years and, to the best of my knowledge, suffered no ill effects. >> May I ask, if it is not approved in the US, how you have been taking for years? Gerry